Drug name - Gralise
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8192756 | ALMATICA | Gastric retained gabapentin dosage form |
Oct, 2022
(22 days from now) | |
| US8333992 | ALMATICA | Gastric retained gabapentin dosage form |
Oct, 2022
(22 days from now) | |
| US8252332 | ALMATICA | Gastric retained gabapentin dosage form |
Oct, 2022
(22 days from now) | |
| US7731989 | ALMATICA | Gastric retained gabapentin dosage form |
Oct, 2022
(22 days from now) | |
| US7438927 | ALMATICA | Methods of treatment using a gastric retained gabapentin dosage |
Feb, 2024
(1 year, 4 months from now) | |
Drugs and Companies using GABAPENTIN ingredient
Treatment: Treatment with gabapentin, including treatment of neuropathic pain, including neuropathic pain associated with postherpetic neuralgia
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 300MG | TABLET;ORAL | Prescription |
| 600MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.